Trailblazing the path to transcription factors by intervening at a previously hidden region we have identified as the ‘switch site.’

 

SWITCHING
THE VIEW

To date, the collective research on transcription factors has been elusive to drug discovery. However, Flare Therapeutics has now reached a moment of light – with the prospect of forever changing the trajectory of how we treat disease.

  Science

 

Flareā€™s pipeline is Initially focused on precision oncology.

Our small molecules are designed to regain transcriptional control that is hijacked by cancer.

  Pipeline

 
 

ENLIGHTEN
YOUR PATH

Intensity, empathy, determination, and brilliance. The Flare Therapeutics team is a living, growing, thriving organization of talented people and bright minds. We are always looking for new sparks to flame our collective fire. Learn more about our culture and join us!

  Join Us

10.25.2021
Flare Therapeutics Appoints Daphne Karydas as COO and CFO, and Michaela Bowden, PhD, as SVP of Biology and Translation
Company expands leadership team across business and science as it advances precision oncology pipeline

  Read full story

 

This links to an external website.

Continue